Here you can find studies currently accepting participants in Australia.
Click on the study names for more information. If you are interested in participating in a study, please contact that study directly.
Are you interested in future research projects? Join our email list and we will send you an email as soon as a new study is added to this page.
| Study Name | Study Focus | Study Aim | State(s) | Who can participate? | Allergy Status |
|---|---|---|---|---|---|
| PEBBLES | Prevention | To find out if infant skin management with a particular cream, called EpiCeram™, might help reduce the chances that a child will develop allergies | VIC | Infants, aged 0-3 weeks (expressions of interest from pregnant women welcome) | Baby to have family history of allergy |
| OPTIMUM | Prevention | To investigate if giving a dose of 'whole-cell' whooping cough vaccine between 6 and 12 weeks of age, instead of the 'acellular' whooping cough vaccine can help protect against allergy | WA | Infants, aged 6-12 weeks | All welcome |
| OPIA | Treatment | To determine whether graded peanut ingestion along with a dietary fibre supplement can train the body to become tolerant to peanut in children with peanut allergy | ACT, NSW | Children/Adolescents, aged 10-16 years | Food allergy – peanut |
| VITALITY | Prevention | To assess whether vitamin D supplementation during infancy can prevent food allergy in the first year of life | VIC | Infants, aged 6-12 weeks | All welcome |
| SYMBA | Prevention | To determine whether maternal prebiotic supplementation during pregnancy and breastfeeding can reduce the development of eczema in babies | WA | Pregnant women, less than 21 weeks gestation | Baby to have family history of allergy |
| PrEggNut | Prevention | To test whether the amount of eggs and peanuts a mother eats during pregnancy and breastfeeding has an influence on her baby’s food allergy development | WA, SA, VIC, NSW | Pregnant women, less than 23 weeks gestation | Baby to have family history of allergy |
| PEAT | Treatment | To test the hypothesis that probiotic and egg OIT is more effective than placebo at inducing sustained unresponsiveness (remission) in participants with egg allergy 8 weeks after end-of-treatment | VIC | Children/Adolescents, aged 5-17 years | Food allergy – egg |
| EPITOPE | Treatment | To evaluate the safety and efficacy of a novel desensitisation method, called EPicutaneous ImmunoTherapy (EPIT) with the Viaskin® Peanut patch in young children | NSW (Westmead), NSW (Randwick), QLD, SA, VIC, WA. | Children, aged 1-3 years | Food allergy – peanut |
Families: Join our email list to receive an email alert each time a new study is added to this page.
Researchers: Please contact us to add your currently recruiting study to this page.
Last modified: October 16th 2019 | Date created: May 28th 2019